289.50€
+
12.50€ (4.51%)
End-of-day quote: 05/14/2024
XTRA:SRT3
Sartorius Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| AZN | AstraZeneca PLC | LSE | Outperform | £122.46 | £165.99 | 0.00% | 16 | £189.84B |
| TMO | Thermo Fisher Scientific | NYSE | Outperform | $594.80 | $591.94 | 0.00% | 1 | $227.04B |
| ROG | Roche Holding | SWX | Hold | CHF224.60 | CHF307.83 | 0.00% | 9 | CHF181.26B |
| DHR | Danaher | NYSE | Outperform | $259.26 | $260.33 | 0.00% | 4 | $192.03B |
| MRK | Merck KGaA | XTRA | Outperform | 158.30€ | 190.06€ | 0.00% | 4 | 68.83€B |
| PH | Parker-Hannifin Corp | NYSE | Outperform | $549.40 | $548.76 | 0.00% | 7 | $70.62B |
| BDX | Becton Dickinson and Co | NYSE | Outperform | $235.00 | $284.47 | 0.00% | 8 | $67.92B |
| A | Agilent Technologies | NYSE | Outperform | $151.28 | $138.82 | 0.00% | 10 | $44.33B |
| BIIB | Biogen | NasdaqGS | Outperform | $226.88 | $299.62 | 0.00% | 13 | $33.03B |
| MTD | Mettler-Toledo International | NYSE | Hold | $1.50k | $1.12k | 0.00% | 0 | $31.95B |
| BAYN | Bayer | XTRA | Hold | 29.22€ | 45.15€ | 0.00% | 4 | 28.71€B |
| STE | STERIS | NYSE | Outperform | $236.00 | $238.33 | 0.00% | 4 | $23.32B |
| ENTG | Entegris | NasdaqGS | Outperform | $130.22 | $116.12 | 0.00% | 11 | $19.64B |
| RGEN | Repligen | NasdaqGS | Outperform | $172.48 | $187.18 | 0.00% | 12 | $9.21B |
| GETI B | Getinge AB | OM | Outperform | kr217.10 | kr226.10 | 0.00% | 3 | kr63.33B |
| 3355 | Kuriyama Holdings | TSE | Outperform | ¥1.22k | ¥0.00 | 0.00% | 0 | ¥18.46B |
